Erratum: Treatment of Dupuytren's Disease: Collagenase Clostridium histolyticum
The Journal publishes corrections when they are of significance to patient care, scientific data or record-keeping, or authorship, whether that error was made by an author, editor, or staff. Errata also appear in the online version and are attached to files downloaded from jbjs.org.
In the article entitled “Treatment of Dupuytren's Disease: Collagenase Clostridium histolyticum” (JBJS JOPA 2020; 8: e0024), by Thomas V. Gocke III, in the “Adverse Effects Associated with CCH Injections” section, the citation of reference 28 following the quote “immune system acts as antigen-presenting cells and collect the collagenase and transport it through the lymph system via the axillary lymph nodes where anti-AUX I and anti AUX II antibodies are produced. This process may cause a local inflammatory response along the lymph vessels” is incorrect. The correct reference number is 36, Sanjuan-Cervero et al.Copyright © 2020 by The Journal of Bone and Joint Surgery, Incorporated.